You Searched For "SII CEO" and got 20 results
Sort By:
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice
"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…
Serum Institute applies to Indian authorities for full market authorisation of Covishield
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine t…
PTI
DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis
"... the new coronavirus variant 'omicron' has already been reported in more than 60 countries and…
PTI
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an …
PTI
SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations
Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…
SII expects nod for Covid-19 vaccine in 'few days'
New Delhi, Dec 28 (IANS) Pune-based Serum Institute of India on Monday expressed hope at the possib…
India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates
The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …
SII launches India's first indigenous pneumonia vaccine at $3 per dose
CEO Adar Poonawalla Roughly stated that SII’s pneumococcal conjugate vaccine will cost the gover…
No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data
New Delhi, Dec 30 (IANS) The analysis of the additional data and information submitted by Serum Ins…
Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla
Pune, Nov 28 (IANS) The Government of India is looking at getting 300-400 million doses of coronavi…
Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia
According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…
SII's Adar Poonawalla says it will take 2-3 years for the entire world population to get fully vaccinated
Serum Institute of India CEO Adar Poonawalla has said that the SII never exported vaccines at the c…
SII to resume Covid vaccine trials once DCGI gives nod (Ld)
New Delhi, Sep 12 (IANS) Serum Institute of India (SII) said on Saturday it will resume trials in I…
In conversation with ALTBalaji CEO Nachiket Pantvaidya on foraying into digital space
Catching up with the trend of going digital, Balaji has come up with a digital platform called A…
SII’s Adar Poonawalla estimates two more months of COVID-19 vaccine shortage in India — and the blame game is heating up
Not only has the number of COVID-19 cases surging in the world’s second most populous country but t…
Adar Poonawalla says SII will seek emergency use authorisation for AstraZeneca COVID-19 vaccine in two weeks
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting …
SII's Oxford-Astra Zeneca COVID-19 vaccine to cost $3-4 to Indian government, price likely to be double in private markets
Only after meeting their requirements, "the private market will open up where the pricin…
PTI
COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence
Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …